Myriad Genetics buy Piper Sandler
Start price
11.11.25
/
50%
€5.70
Target price
11.11.26
€7.36
Performance (%)
-31.93%
Price
27.02.26
€3.88
Summary
This prediction is currently active. The BUY prediction by Piper_Sandler for Myriad Genetics is performing very badly with a performance of -31.93%. This prediction currently runs until 11.11.26. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Myriad Genetics | 6.593% | 6.593% |
| iShares Core DAX® | -0.383% | 1.093% |
| iShares Nasdaq 100 | -0.411% | -1.973% |
| iShares Nikkei 225® | 1.838% | 10.261% |
| iShares S&P 500 | -0.712% | 0.445% |
Comments by Piper_Sandler for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics (NASDAQ:MYGN) had its price target lowered by analysts at Piper Sandler from $9.00 to $8.50. They now have an "overweight" rating on the stock.
Ratings data for MYGN provided by MarketBeat